Follow the Shanghai MicroPort MedBot (Group) Co., Ltd. - B stock price and the full management transaction log of the company, a listed equity based in Hong Kong. Shares trade on the HK market, under the authority of HKEX. Operating in the Health Care sector, Shanghai MicroPort MedBot (Group) Co., Ltd. - B has recorded 1 insider filings. Market capitalisation: €21.4bn. The latest transaction was reported on 9 April 2026 (Purchase). Among the most active insiders: Liang Min. All data is free.
Analysts rate Shanghai MicroPort MedBot (Group) Co., Ltd. - B Strong Buy (bullish), based on 10 analysts. Average price target: HK$36.15.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Shanghai MicroPort MedBot (Group) Co., Ltd. es una empresa centrada en el desarrollo de tecnologías médicas y robots quirúrgicos. Cotiza en la Bolsa de Hong Kong.